Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Retained Earnings	Accumulated Other Comprehensive Loss
Balance at beginning of period at Oct. 31, 2018	$ 668,916	$ 105,601	$ 587,252	$ (23,937)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cash dividends paid on common stock	(23,923)		(23,923)
Issuance of shares for stock options exercised and restricted stock units vested	6,165	538	5,627
Stock-based compensation expense	3,924		3,924
Contribution of stock to a deferred compensation trust	1,404		1,404
Purchase of common stock	(21,915)	(392)	(21,523)
Other comprehensive loss	(578)			(578)
Net earnings	59,540		59,540
Balance at end of period at Feb. 01, 2019	694,397	105,747	613,165	(24,515)
Balance at beginning of period at Oct. 31, 2019	859,578	106,742	784,885	(32,049)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cash dividends paid on common stock	(26,856)		(26,856)
Issuance of shares for stock options exercised and restricted stock units vested	4,142	253	3,889
Stock-based compensation expense	3,960		3,960
Contribution of stock to a deferred compensation trust	2,568		2,568
Purchase of common stock	(1,361)	(18)	(1,343)
Other comprehensive loss	(72)			(72)
Net earnings	70,091		70,091
Balance at end of period at Jan. 31, 2020	$ 912,050	$ 106,977	$ 837,194	$ (32,121)